
    
      A Randomized, Double-Blind, Parallel Group, 52-week Study to Compare the Effect of the
      Fluticasone Propionate/Salmeterol DISKUS® inhaler Combination Product 250/50mcg twice daily
      (BID) with Salmeterol DISKUS® inhaler 50mcg BID on the Annual Rate of Moderate/Severe
      Exacerbations in Subjects with Chronic Obstructive Pulmonary Disease (COPD)
    
  